How to attract, engage and retain healthcare professionals

The Pharma Launch KPI Framework: From Reach to Growth

Building a future-ready framework for Medical Affairs

How to measure congress success in pharma: from booth visitors to behavioural change

Medical Affairs as a driver of maximum health gain

AI in Medical Affairs: Why context is the key to better AI output

How open-access AI tools can support pharma market access work

What does a structured AI approach in BD&L actually look like?

Why healthcare decision-making in Europe is about value for money

AI in pharma: from problem solver to problem explainer

The difference between Patient FLOW and Patient JOURNEY

From Patient Flows & Journeys to CSFs – The best approach

Pharma lead generation strategy: how to build an always-on, insight-driven funnel

Why story wins in the AI era and what that means for HCP engagement

How MFN pricing is changing launch and access decisions in Europe

How much is a payer willing to pay for a QALY gain? – By Prof. Dr. Lieven Annemans

What does business acumen for MSLs mean?

The 6 principles of good pharma forecasting by Gary Johnson, CELforPharma faculty member

The Pharma Licensing Process Overview - a Presentation by David Scott

What are the different types of payers? by Gary Johnson, CELforPharma faculty member

What is a QALY and how to calculate it? By Prof. Dr Lieven Annemans, CELforPharma faculty member

What is AI & Machine Learning and why compare it to Econometrics/Extrapolation in pharma forecasting

9.5 steps to a successful Advisory Board Meeting

Introduction "Health Economics for Non-Health-Economists" by Prof. Dr. Lieven Annemans

Pharma Brand Planning Challenges